Blog

Nelson Advisors has been invited to Chair the HealthTech M&amp;A Panel at Global Health Exhibition’s 2026 Capital Xchange Forum in Riyadh, Saudi Arabia #GHE2026Source: <a href="https://connections.globalhealthsaudi.com/event/global-health-exhibition2026/person/RXZlbnRQZW9wbGVfNDc5NTU5Mzk=">https://connections.globalhealthsaudi.com/event/global-health-exhibition2026/person/RXZlbnRQZW9wbGVfNDc5NTU5Mzk=</a>The Capital Xchange Forum is the thought-leadership platform of the Capital Xchange Programme, designed to convene the key players shaping healthcare investment in Saudi Arabia and beyond. Through a curated agenda of talks and panel discussions, the forum examines capital flows, emerging healthcare opportunities, innovation transfer, ecosystem readiness and the role of government in unlocking investment at scale.From identifying the next major capital movers to addressing gaps in healthcare delivery, policy and investability, the forum creates a platform for meaningful dialogue on how healthcare systems, investors and institutions can work together to turn opportunity into real market outcomes.Connecting Capital, Innovation &amp; Healthcare TransformationThe Capital Xchange Programme is the evolution of the Global Health Exhibition Investor Programme, designed as a curated platform for global investors, innovators and government stakeholders driving healthcare transformation.By bringing together capital providers, high-growth healthcare companies and Saudi policy leaders, the programme creates pathways for strategic investment, partnerships and market entry within one of the world’s fastest growing healthcare markets.&nbsp;Participants gain direct insight into regulatory frameworks, emerging opportunities and the priorities shaping Saudi Arabia’s Vision 2030 healthcare transformation.<a href="https://www.globalhealthsaudi.com/investors-and-startups/invest-in-health/">https://www.globalhealthsaudi.com/investors-and-startups/invest-in-health/</a>

Nelson Advisors invited to Chair the HealthTech M&A Panel at Global Health Exhibition’s 2026 Capital Xchange Forum in Riyadh, Saudi Arabia #GHE2026

Nelson Advisors has been invited to Chair the HealthTech M&amp;A session at the Healthcare Summit &nbsp;2026.Source: <a href="https://healthcare-summit.co.uk/agenda-2026/health-tech-founders-panel?&amp;sortby=customfield_2627%20asc&amp;filters.STREAM=health-tech&amp;searchgroup=libraryentry-agenda-2026" data-mce-href="https://healthcare-summit.co.uk/agenda-2026/health-tech-founders-panel?&amp;sortby=customfield_2627%20asc&amp;filters.STREAM=health-tech&amp;searchgroup=libraryentry-agenda-2026">https://healthcare-summit.co.uk/agenda-2026/health-tech-founders-panel?&amp;sortby=customfield_2627%20asc&amp;filters.STREAM=health-tech&amp;searchgroup=libraryentry-agenda-2026</a>On Tuesday 22nd September 2026, the Business Design Centre in Islington will once again become the meeting point for the UK's healthcare economy as the Healthcare Summit returns to London. Produced by Nexus Media Group in partnership with HealthInvestor UK and Caring Times, the one-day event has established itself as one of the most significant fixtures in the sector's calendar, drawing together the operators who deliver care, the investors who fund it, and the advisors who shape its transactions. The scale of the summit reflects the breadth of the market it serves.&nbsp;Around 1,000 attendees are expected through the doors between 9am and 5pm, alongside some 30 exhibitors and a programme featuring roughly 60 speakers. Attendance is free for providers, meaning care and healthcare professionals working across the NHS, local authorities and private care settings can access the full programme at no cost — a deliberate move to keep frontline operators at the heart of the conversation rather than pricing them out of it.What distinguishes the Healthcare Summit from more generalist conferences is its structure. Rather than a single plenary track, the day is divided into specialist streams, each targeting a distinct constituency within the healthcare ecosystem. A CFO stream addresses financial management and the operational pressures facing finance leaders; a CTO stream tackles digital health and the technology agenda; and dedicated streams cover dental, social care, complex care and healthcare property. A "public to private" stream examines one of the defining dynamics of the current market — the shifting boundary between NHS provision and independent-sector delivery.The speaker roster underlines the event's convening power. Chief executives from some of the UK's largest healthcare operators, including Nuffield Health, Priory Group and Barchester Healthcare — share the platform with investment managers, legal experts and innovators spanning dental, mental health, social care and medical technology. For delegates, that mix creates rare opportunities: an operator can hear directly from the capital providers assessing their sector, while investors gain unfiltered insight into the realities of running services under regulatory and workforce pressure.For anyone operating in, investing in or advising the UK healthcare sector, the Healthcare Summit on 22nd September offers a concentrated, efficient snapshot of where the market stands and where it is heading next. Registration details are available at healthcare-summit.co.ukHealth Tech Founders Panel&nbsp;The Health Tech Founders Panel is a session in the Health Tech stream at the Healthcare Summit 2026, taking place on Tuesday 22 September 2026 from 14:10 to 14:50 at the Business Design Centre, 52 Upper Street, London N1 0QH. The session sits within the summit's overarching theme of "Prevention Not Cure" and forms part of a full-day conference programme running from 09:00 to 17:00.The panel is chaired by Lloyd Price, Partner at Nelson Advisors, a healthtech M&amp;A and growth advisory firm. He is joined by four founders and chief executives who have built and scaled UK digital health businesses: Hamish Grierson, CEO and Co-Founder of Thriva Health, the at-home blood testing and preventative health platform; Edward Ungar, Co-Founder and CEO of Pharmacierge, the private prescribing and pharmacy technology company; Reece Donovan, CEO of Mayden, the provider of the iaptus electronic patient record system used widely across NHS mental health services; and Rachael Crook, CEO and Founder of Lifted, the technology-enabled home care provider.The 40-minute discussion brings these entrepreneurs together to explore innovation across the health technology sector, drawing on their first-hand experience of founding, funding and growing companies that serve patients, clinicians and the NHS. Topics are likely to include the shift towards preventative care, the practical realities of selling into the health system, and lessons learned along the founder journey.#HCSummit26<a href="https://healthcare-summit.co.uk/">https://healthcare-summit.co.uk/</a>

Nelson Advisors invited to Chair the HealthTech Founders panel at HealthInvestor’s 2026 Healthcare Summit in London

Nelson Advisors have been invited to join the UCL Investment Society Conference 2026 as a Panelist discussing recent trends in European Mergers &amp; Acquisitions. &nbsp;The UCL Investment Society (UCLIS) Finance Conference is the flagship annual event organised by the UCL Investment Society, one of the largest and oldest student-led finance events in the Europe, Middle East, and Africa (EMEA) region.Source: <a href="https://sites.google.com/uclis.co.uk/uclinvestmentsociety/uclis-finance-conference" data-mce-href="https://sites.google.com/uclis.co.uk/uclinvestmentsociety/uclis-finance-conference">https://sites.google.com/uclis.co.uk/uclinvestmentsociety/uclis-finance-conference</a>Key HighlightsIndustry Keynotes &amp; Speaker Panels: High-profile keynotes and executive panels featuring leaders from global financial institutions like J.P. Morgan, Goldman Sachs, Morgan Stanley, Citi, and HSBC.&nbsp;Competitions &amp; Workshops: Interactive sessions including financial valuation workshops (DCF, comparable analysis) and practical stock pitch competitions (such as the Jefferies Stock Pitch).Recruitment &amp; Networking: Direct access to firm recruiters, alumni, and analysts for 1-on-1 networking to help delegates land Spring Weeks, summer internships, and graduate roles.Source: <a href="https://studentsunionucl.org/clubs-societies/investment-society" data-mce-href="https://studentsunionucl.org/clubs-societies/investment-society">https://studentsunionucl.org/clubs-societies/investment-society</a>UCL Investment Society Conference 2025The 17th edition of the UCL Finance Conference, organized by the UCL Investment Society (UCLIS), took place on October 24th 2025 at The Waldorf Hilton Hotel in Central London. It brought together 150 selected delegates, industry leaders, and alumni for a full day of keynotes, workshops, and high-impact networking.Conference Highlights &amp; Agenda1. Keynote &amp; Industry LeadersThe conference featured insightful talks on financial markets, leadership, and macro trends from senior leaders across top global firms:Stephen Paine – Global Head of Infrastructure &amp; Utilities, Deutsche BankMichael Lavelle – Head of Banking, Capital Markets &amp; Advisory (UK &amp; Ireland), CitiLia Larson – Partner &amp; Head of Investment Banking Client Service EMEA, Goldman SachsArdal Loh-Gronager – Managing Partner, Loh-Gronager Partners2. Practical Competitions &amp; Interactive SessionsJefferies Stock Pitch Competition: Delegates pitched live trade ideas and received feedback and guidance from Jefferies professionals.Division Deep Dives: In partnership with Barclays, students engaged directly with professionals spanning private banking, wealth management, capital markets, and corporate banking.3. Alumni PanelThe event featured a dedicated alumni discussion offering real-world career trajectory advice from recent UCL graduates working across bulge-bracket banks and buy-side firms.

Nelson Advisors have been invited to join the UCL Investment Society Conference 2026 as a Panelist discussing recent trends in European Mergers & Acquisitions

Nelson Advisors: This Week in European HealthTech, MedTech and Health AI: 11th September 2026.Activity across European HealthTech this week centred on remote patient monitoring, clinical AI infrastructure, and EU-backed commercial rollouts: &nbsp;&nbsp; Implicity secures €35M to expand cardiac AI monitoring: French healthtech startup Implicity announced a €35 million growth round led by IRIS. The company’s SaMD (Software as a Medical Device) platform aggregates and normalizes telemetry data from cardiac implantable electronic devices (CIEDs) across major hardware manufacturers. The capital will fund international expansion—particularly into the US—and further train proprietary predictive algorithms for heart failure exacerbations. &nbsp;&nbsp; Check Point Care accelerates European hospital pilots: Bulgarian remote monitoring developer Check Point Care secured hospital pilot agreements and crossed 10,000 pending orders for its AI-integrated patient monitoring wearables. The scaling milestone was facilitated via the European Innovation Council (EIC) Accelerator matchmaking and trade framework. &nbsp;&nbsp; Institutional push for domain-specific clinical models: Procurement trends across UK, German, and Nordic health networks continue tilting toward specialised, vertical medical models over generalised LLMs. Clinical validation data released by Danish healthcare AI company Corti underscored this shift, showing specialised diagnostic and administrative coding engines outperforming broader foundation models in hospital electronic health record (EHR) environments. &nbsp;&nbsp; Regulatory sandboxing under the EU AI Act: European MedTech trade bodies and health regulators intensified alignment on regulatory sandboxes. Following the recent enforcement milestones of the EU AI Act, these sandboxes are being coordinated alongside Medical Devices Regulation (MDR) transition paths to give clinical software and diagnostic startups a pathway to validate models in live environments without duplicative compliance delays.Click here to read the article in full <a href="https://www.healthcare.digital/single-post/nelson-advisors-this-week-in-european-healthtech-medtech-and-health-ai-11th-september-2026">https://www.healthcare.digital/single-post/nelson-advisors-this-week-in-european-healthtech-medtech-and-health-ai-11th-september-2026</a>

Nelson Advisors: This Week in European HealthTech, MedTech and Health AI: 11th September 2026

For fifteen years the smartest money in HealthTech had a simple thesis. Software eats the world, healthcare is the biggest and slowest-moving industry on earth, and so the biggest returns would come from software companies that digitised, automated and re-platformed the way care is delivered, paid for and administered. Asset-light, high gross margin, infinitely scalable and defended by data, workflow lock-in and the sheer difficulty of selling into hospitals and payers. &nbsp;&nbsp; That thesis is now under real pressure and the pressure is coming from the very technology that was supposed to be its next chapter. Generative AI has made software cheaper to build, faster to copy and harder to defend than at any point since the cloud era began. The question every board, every investment committee and every founder in HealthTech is now asking is the same one: what, exactly, is our moat when a foundation model can generate our product? &nbsp;&nbsp; This post argues that one of the most important answers to that question in 2027 will be physical. We expect a visible shift in both investor appetite and founder ambition towards HealthTech companies that build hardware, or that own a hardware layer as part of a full-stack proposition. Not because hardware is easy, but precisely because it is hard and because hardness is what defensibility looks like in a world where software has become abundant.The M&amp;A lens &nbsp;&nbsp; From where we sit, advising founders and boards on transactions in the lower to mid market, the shift is already visible in the conversations we have. &nbsp;&nbsp; Strategic buyers are prioritising targets that bring them a device, a sensor, a signal or a manufacturing capability they cannot build internally, and they are willing to pay for regulatory clearance, clinical evidence and installed base. They are more sceptical of software-only assets unless those assets are deeply embedded and demonstrably resistant to substitution.&nbsp; &nbsp; Due diligence has changed accordingly: the defensibility section of the process now asks explicitly how the business would be affected by the next generation of foundation models, and hardware-enabled companies have an easier time answering. &nbsp;&nbsp; We expect 2027 to bring more acquisitions of hardware-enabled HealthTech companies by medtech, diagnostics, pharma and, increasingly, by large technology companies building health-hardware ecosystems. We expect more software companies to seek hardware partners or acquisitions of their own to shore up their defensibility and more hardware companies to acquire software and AI teams to complete their stack. We also expect private equity, which has historically preferred the predictable cash flows of healthcare software, to build increasing comfort with hardware-enabled recurring revenue models, particularly where consumables and service contracts provide the annuity that software subscriptions used to. &nbsp;&nbsp; For founders contemplating an exit, the practical implication is that the story the market wants to hear has changed. It is no longer enough to show growth and gross margin. Buyers want to know what you own that cannot be generated, and in 2027 the most convincing answer to that question will increasingly be something you can hold in your hand. &nbsp;&nbsp; Conclusion &nbsp;&nbsp; The software era of HealthTech is not ending, but its unquestioned dominance is. Generative AI has made software abundant, and abundance is the enemy of defensibility. The companies that will command premium valuations, attract the most durable capital and achieve the strongest exits over the next few years will be the ones that anchor their intelligence in the physical world, in devices that capture signals nobody else can capture, that clear regulatory bars nobody else has cleared, and that sit in clinical and consumer settings nobody else can reach. &nbsp;&nbsp; We expect 2027 to be remembered as the year that HealthTech investors and founders stopped treating hardware as the difficult, capital hungry cousin of software and started treating it as the foundation of a defensible business. The moat, it turns out, was never the code. It was the thing the code runs on.Click here to read the article in full <a href="https://www.healthcare.digital/single-post/nelson-advisors-healthtech-2027-and-the-big-move-from-software-to-hardware-to-de-risk-the-ai-threat">https://www.healthcare.digital/single-post/nelson-advisors-healthtech-2027-and-the-big-move-from-software-to-hardware-to-de-risk-the-ai-threat</a>

Nelson Advisors: HealthTech 2027 and the Big Move From Software to Hardware to De-Risk the AI Threat and address the Defendability questions

Nelson Advisors Partner Paul Hemings has been invited to speak on the 'Health Tech Deal Structuring Panel' at Healthcare Summit 2026.Source: <a href="https://healthcare-summit.co.uk/agenda-2026/health-tech-deal-structuring-panel">https://healthcare-summit.co.uk/agenda-2026/health-tech-deal-structuring-panel</a>Healthcare Summit 2026 takes place on Tuesday 22nd September 2026 at the Business Design Centre, 52 Upper Street, Islington, London N1 0QH, running from 09:00 to 17:00. Organised by Nexus Media Group, the one-day event is positioned under the banner "Leading the Agenda for the Future of Healthcare" and is designed to bring together the operators, investors and advisors who shape the UK's private and public health and care markets. The organisers expect around 1,000 attendees, 30 exhibitors and more than 100 speakers, making it one of the larger cross-sector gatherings in the UK healthcare calendar.The summit's stated purpose is to provide market updates, expert insight and structured networking across the full breadth of the sector. Rather than a single plenary track, the programme is broken into a series of specialist streams that allow delegates to follow the themes most relevant to their business. These include a CFO Stream focused on finance, funding and margin pressure; a CTO Stream covering digital infrastructure and technology leadership; a dedicated Health Tech Stream looking at innovation and its adoption; and a Property Stream addressing healthcare real estate, development and sale-and-leaseback activity. Sector-specific streams cover Dental, Social Care and Complex Care, while a Public to Private Stream examines the growing interface between NHS commissioning and independent provision, including outsourcing, insourcing and partnership models.The speaker line-up reflects that mix of provider, policy and investor perspectives. Confirmed names include Alex Perry, Chief Executive of Nuffield Health; Barny Guthrie, CEO of Clinical Partners; Tim Davies, CEO of ivolve Group; Sarah Woolnough, Chief Executive of The King's Fund; and Chris Hopson, former Chief Strategy Officer at NHS England. Between them they span the largest independent healthcare charity, mental health services, specialist care, health policy think-tank leadership and senior NHS strategy, which signals that the content will move between commercial operating realities and the wider system-level agenda.The sponsor and partner roster is heavily weighted toward the advisory and capital ecosystem that supports healthcare transactions and operations. Care Inspections UK is the main sponsor. Banking partners include Barclays, Virgin Money, NatWest and HSBC, indicating a strong lending and deal-finance presence. Legal partners include DAC Beachcroft, Ashfords, Freeths and Hill Dickinson, all firms with established healthcare and social care practices. Technology partners include OneAdvanced, RLDatix and Cloda, covering care management software, patient safety and risk platforms, and workforce and data tools.Access is deliberately broad. The event is marketed to healthcare investors, advisors and operators, but complimentary tickets are offered to UK care and healthcare professionals working within the NHS, CCG or ICB bodies, local authorities, primary and secondary care, private hospitals, private care and social care. This free-entry policy for frontline and public-sector delegates is a notable feature and helps explain the scale of the audience. Paid tickets, along with sponsorship and exhibition packages, are available through the event website.The summit is a concentrated opportunity to meet operators, lenders, law firms and investors active in UK health and care M&amp;A on a single day, with the specialist streams, particularly CFO, Property, Public to Private and Health Tech, offering the clearest view of where capital and deal activity are heading into 2027.<a href="https://healthcare-summit.co.uk/">https://healthcare-summit.co.uk/</a>

Nelson Advisors

Blog

Nelson Advisors invited to Chair the HealthTech M&A Panel...

Nelson Advisors invited to Chair the HealthTech Founders ...

Nelson Advisors have been invited to join the UCL Investm...

Nelson Advisors: This Week in European HealthTech, MedTec...

Nelson Advisors: HealthTech 2027 and the Big Move From So...

Nelson Advisors Partner Paul Hemings invited to speak on ...